MedPath

ACCELAGEN PTY LTD

🇳🇿New Zealand
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Phase 1:2
Phase 3:1

Drug Approvals

50

TGA:50

Drug Approvals

MSN-SAFINAMIDE safinamide (as mesilate) 50 mg tablet blister pack (449610)

Product Name
MSN-SAFINAMIDE safinamide (as mesilate) 50 mg tablet blister pack
Approval Date
Jul 8, 2025
TGA

MSN-SAFINAMIDE safinamide (as mesilate) 100 mg tablet blister pack (449609)

Product Name
MSN-SAFINAMIDE safinamide (as mesilate) 100 mg tablet blister pack
Approval Date
Jul 8, 2025
TGA

BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial (453648)

Product Name
BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial
Approval Date
Jun 11, 2025
TGA

SUGAMMADEX MSN sugammadex (as sodium) 500 mg/5 mL solution for injection vial (421352)

Product Name
SUGAMMADEX MSN sugammadex (as sodium) 500 mg/5 mL solution for injection vial
Approval Date
Jan 12, 2024
TGA

SUGAMMADEX MSN sugammadex (as sodium) 200 mg/2 mL solution for injection vial (421351)

Product Name
SUGAMMADEX MSN sugammadex (as sodium) 200 mg/2 mL solution for injection vial
Approval Date
Jan 12, 2024
TGA

TICALOR ticagrelor 90 mg tablet blister pack (377470)

Product Name
TICALOR ticagrelor 90 mg tablet blister pack
Approval Date
Oct 6, 2022
TGA

SUNITINIB MSN sunitinib (as malate) 12.5 mg hard capsule bottle (370765)

Product Name
SUNITINIB MSN sunitinib (as malate) 12.5 mg hard capsule bottle
Approval Date
Jul 22, 2022
TGA

SUNITINIB MSN sunitinib (as malate) 50 mg hard capsule bottle (370767)

Product Name
SUNITINIB MSN sunitinib (as malate) 50 mg hard capsule bottle
Approval Date
Jul 22, 2022
TGA

SUNITINIB MSN sunitinib (as malate) 50 mg hard capsule blister pack (370768)

Product Name
SUNITINIB MSN sunitinib (as malate) 50 mg hard capsule blister pack
Approval Date
Jul 22, 2022
TGA

SUNITINIB MSN sunitinib (as malate) 37.5 mg hard capsule blister pack (370770)

Product Name
SUNITINIB MSN sunitinib (as malate) 37.5 mg hard capsule blister pack
Approval Date
Jul 22, 2022
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 3
1 (33.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.